These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28363823)

  • 1. Sustained tocilizumab-induced hypofibrinogenemia and thrombocytopenia. Comment on: "Tocilizumab-induced hypofibrinogenemia: A report of 7 cases" by Martis et al., Joint Bone Spine 2016, doi: 10.1016/j.jbspin.2016.04.008.
    Vitiello G; Orsi Battaglini C; Radice A; Carli G; Micheli S; Cammelli D
    Joint Bone Spine; 2017 Oct; 84(5):649-650. PubMed ID: 28363823
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
    Martis N; Chirio D; Queyrel-Moranne V; Zenut MC; Rocher F; Fuzibet JG
    Joint Bone Spine; 2017 May; 84(3):369-370. PubMed ID: 27324602
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review.
    Üsküdar Cansu D; Demirtaş E; Andiç N; Üsküdar Teke H; Korkmaz C
    Rheumatol Int; 2019 Apr; 39(4):743-750. PubMed ID: 30874871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic approach and novel therapeutic option for cardiac inflammatory disorders. Comment on "Antisynthetase syndrome and cardiac involvement: a rare association" by Meudec et al. Joint Bone Spine 2018. doi: 10.1016/j.jbspin.2018.09.019.
    Sartorelli S; Campochiaro C; De Luca G
    Joint Bone Spine; 2019 May; 86(3):407. PubMed ID: 30738848
    [No Abstract]   [Full Text] [Related]  

  • 6. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis.
    Uchiyama Y; Yorozu K; Hashizume M; Moriya Y; Mihara M
    Biol Pharm Bull; 2008 Jun; 31(6):1159-63. PubMed ID: 18520048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab in the treatment of giant cell arteritis.
    Leuchten N; Aringer M
    Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab].
    Spertini F
    Rev Med Suisse; 2017 Jan; 13(544-545):20-22. PubMed ID: 28703529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on: "Gluten or no gluten for rheumatic diseases?" by Philippou E et al. Joint Bone Spine 2022;105453. doi: 10.1016/j.jbspin.2022.105453.
    Cafaro G; Perricone C; Gerli R; Bartoloni E
    Joint Bone Spine; 2023 Jan; 90(1):105471. PubMed ID: 36273794
    [No Abstract]   [Full Text] [Related]  

  • 10. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
    Nishimoto N
    Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of organizing pneumonia induced by tocilizumab.
    Ikegawa K; Hanaoka M; Ushiki A; Yamamoto H; Kubo K
    Intern Med; 2011; 50(19):2191-3. PubMed ID: 21963739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of tocilizumab, an antibody against interleukin-6 receptor, for the treatment of neuromyelitis optica].
    Yamamura T; Araki M
    Brain Nerve; 2014 Oct; 66(10):1159-65. PubMed ID: 25296870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
    [No Abstract]   [Full Text] [Related]  

  • 14. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab in Giant Cell Arteritis.
    Mariano VJ; Frishman WH
    Cardiol Rev; 2018; 26(6):321-330. PubMed ID: 29570475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways.
    Wu TC; Chiang CY; Chan JS; Lee CY; Leu HB; Huang PH; Chen JS; Lin SJ; Chen JW
    J Interferon Cytokine Res; 2018 Nov; 38(11):510-516. PubMed ID: 30383519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab: an interleukin-6 receptor inhibitor for the treatment of rheumatoid arthritis.
    Plushner SL
    Ann Pharmacother; 2008 Nov; 42(11):1660-8. PubMed ID: 18957621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
    Matsuyama M; Suzuki T; Tsuboi H; Ito S; Mamura M; Goto D; Matsumoto I; Tsutsumi A; Sumida T
    Intern Med; 2007; 46(11):771-4. PubMed ID: 17541233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.